Appointments at Oso BioPharmaceuticals, Creabilis SA and Clondalkin – People on the move
Oso BioPharmaceuticals Manufacturing has appointed Susan Schniepp as vice president of quality. Schniepp previously served as chair of the monograph development-psychiatrics and psychoactives expert committee for the US Pharmacopeia.
Eliot Forster has joined Creabilis SA as CEO. Before joining Creabilis Forster worked at Solace Pharmaceuticals and Pfizer. He is also a non-executive director at Atlantic Healthcare and Oxford BioTherapeutics.
Clondalkin Group has named Mark Rooney as chief operating officer for its specialist packaging group. Rooney has experience in the pharma and healthcare sectors and will support Clondalkin’s growth plans within these sectors.
Sik Siu Kwan has joined the board of directors at Duoyuan Printing. Sik is an independent non-executive director of Simcere Pharmaceutical Group and has more than 20 years of experience in investment banking and finance.
Laureate Pharma has hired Steven Johnson as vice president (VP), business development. Johnson joins from Lonza and has also worked at Degussa Fine Chemicals and Merck & Co.
Glenn Kazo has been appointed president of Prolong Pharmaceuticals, replacing Abraham Abuchowski who continues as CEO. Kazo co-founded Enzon Pharmaceuticals in 1981 with Abuchowski and later worked at Focal and XTL Biopharmaceuticals.
Mersana Therapeutics has named Nicholas Bacopoulos as president and CEO, succeeding Julie Olson who has been appointed as chief technology officer. Bacopoulos has served on the board of directors at Mersana since 2007.
Neil Flanzraich has joined the board of directors at Tigris Pharmaceuticals as executive chairman.Flanzraichalso serves as chairman of ParinGenix and is the founder of Leviathan Biopharma Group.
